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ABSTRACT
We report a case of hemoglobin SC disease complicated by fatal pulmonary 
thromboembolism in a 15 year-old Brazilian boy, submitted to autopsy. This 
case shows the importance of early diagnosis and treatment of sickle cell 
disease, which generates systemic involvement in youth and the importance 
of considering the hypercoagulability in these patients. The autopsy was very 
instructive, revealing the florid morphologic aspect of sickle cell disease and 
its complications.
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CLINICAL SUMMARY
A 15 year-old Brazilian male with diagnosis of 
Hemoglobin SC disease, confirmed by hemoglobin 
electrophoresis (Table 1) was admitted to the 
emergency room complaining of severe left hip pain, 
accompanied by local hyperemia and movement 
limitation. He reported daily fever of 38 to 39 °C for 
the last 11 days. The patient had a past history of 
surgery due to avascular necrosis of the left femoral 
head 5 years ago.
His phisycal examination nothing added to 
the patient’s complaints. Ultrasonography of the 
hips showed signs of joint effusion and synovial 
thickening in the left hip. Laboratory tests on 
admission are shown in Table 2.
Abdominal ultrasonography revealed a 
slightly enlarged liver and billiary tract without signs 
of cholecistopathy. Spleen was not visualized.
Total abdominal and pelvic computed 
tomography scan revealed deformity of femoral 
heads, subchondral cysts and sclerosis, more 
pronounced on the right. There was a tubular bone 
defect in the left femoral neck, probably due to prior 
orthopedic surgery. Bilateral hip joint effusion was 
present, being greater on the left. Hepatomegaly 
and a normal-sized spleen, presenting multiple 
hypodense nodules, probably solids, measuring up 
to 2.0 cm. Biliary tract, pancreas, adrenals, kidneys, 
bladder and aorta were normal.
A left hip arthrocentesis was performed, with 
drainage of a dark brown fluid. Septic artrithis was 
suspected. The pacient was prescribed oxacillin 
and gentamicin and an emergency surgery for 
debridement and drainage on the left hip was 
performed.
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Table 1 – Hemoglobin electroforesis
Abnormal values are highlighted
Hemoglobin A: (%) 0.0
Hemoglobin C: (%) 48.5
Hemoglobin S: (%) 50.5
Hemoglobin F: (%) 1.0
Presence of Hemoglobin SC. Osmotic resistance in NaCl 0,36% - 
positive.
Table 2 – Laboratory data on admission
Exam Unit Value RV
CC-reactive protein mg.L–1 331.4 <5.0
Fibrinogen mg.dL–1 1652.0 16.0-465.0
AST U.L–1 24.0 10.0-36.0
ALT U.L–1 25.0 24.0-59.0
Sodium mEq.L–1 135.0 135.0-145.0
Potassium mEq.L–1 4.8 3.5-5.0
Creatinine mg.dL–1 0.6 0.39-0.87
Urea mg.dL–1 22.0 10.0-45.0
Hemoblobin g% 9.0 14.4-16.6
Hematocrit % 25.6 43.0-49.0
MCV fL 76.9 86.0-94.0
MCH pg 27.0 28.0-32.0
Leukocytes mm3 14790.0 4,5-12,0
Neutrophil % 63.3 53.0-57.0
Eosinophils % 0.7 2.5-2.6
Lymphocytes % 29.5 35.0-37.0
Monocytes % 6.2 0.0
Platellets mm3 1235000.0 140000.0-450000.0
APTT s 56.7 29.5
INR 1.28
(Abnormal values are highlighted), RV = reference value, AST = aspartate transaminase, ALT = alanine transaminase, MCV = mean corpuscular 
volume, MCH = mean corpuscular hemoglobin, APTT = activated partial thromboplastin time, INR = international normalized.
Synovial fluid analysis showed no 
microorganisms on bacterioscopy neither its culture 
was positive for bacterial or fungus growth.
Two days after the surgery, he presented 
acute dyspnea and abdominal pain. On examination, 
the patient was tachycardic, hypotensive and 
tachydyspneic, showing oxymetry 72%, evolving to 
cardiac arrest.
AUTOPSY FINDINGS
On external examination, the anthropometric 
measures revealed the body of a young man 
with 170 cm of heigh, weighting 46 kg, showing 
acrocyanosis, pale mucous membranes and mild 
jaundice. A recent surgical scar of 10 cm on the 
left thigh was seen, where a small hematoma and 
necrotic tissue were enclosed. No pus was found.
Right and left lungs weighed 256 and 234 g 
(normal: 325 to 570 g)* respectively. The external 
surface was smooth, gray with anthracotic deposits. 
On sectioning, the parenchyma was aerated, had 
spongy consistency, reddish colour and crepitation 
was preserved (Figure 1A). There were multiple 
thrombi and blood clots in the pulmonary vessels in 
all lobes, bilaterally (Figure 1B). No pleural effusion 
* Finkbeiner WE, Ursell PC, Davis RL. Autopsy pathology: a manual and 
atlas. 2nd ed.; p. 333-5.
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Figure 1 – A - Right lung (inside view); B - Thrombi in pulmonary vessels (close view); C - Photomicrography 
- Thrombus in pulmonary vessel (H&E, 50X); D - Photomicrography - Sickle red blood cells in pulmonary 
vessels (H&E, 400X).
was detected. Histological examination confirmed 
pulmonary thromboembolism and revealed old and 
recent thrombi in pulmonary vessels (Figure 1C) 
and areas of pulmonary hemorrhagic infarction. 
Sickled red blood cells were observed (Figure 1D). 
There were not signs of pulmonary hypertension or 
inflammatory exudates.
Spleen was decreased in size and volume, 
weighting 72 g (normal: 150 to 200 g), with a 
smooth and purplish capsule. On sectioning, the 
parenchyma was congested, with hard consistency 
and multiple fibrotic whitish spots. Multiple well 
circunscribed congested/ hemorrhagic nodules, 
dark red, soft, measuring up to 2 cm were observed 
(Figures 2A and 2B). Histological examination 
revealed a depleted white pulp, multiple old and 
recent infarcts (Figure 2C and 2D), with areas of 
fibrosis (Figure 3C), hemorrhage, calcification, 
hemosiderin deposition (Figure 3D) and Gamna-
Gandy bodies. (Figure 3B) The nodules described 
on gross examination were represented by more 
preserved congested areas (Figure 3A).
The brain weighed 1310 g (normal: 1410 g), 
and showed cortical edema and congested vessels, 
filled with sickled erythrocytes.
The liver weighed 2144 g (normal: 1500 to 
1800 g), presenting congestion, with the presence 
of sickled red blood cells and a slight portal 
lymphocytic infiltrate. (Figure 4A and 4B).
Right and left kidneys weighed 170 and 
192 g (normal: 115 to 220 g), respectively. The 
capsule was easily detached and showed smooth 
and gray outer surface. On sectioning, there 
were no lesions. Histology showed glomerular 
and vascular congestion with sickled erytrocytes 
(Figure 5A and 5B).
The bone marrow was hypercellular 
(approximately 90% of hematopoietic cells), with 
increase of both erythroid and myeloid lines. 
Sinusoids were congested, containing sickled red 
cells (Figure 6).
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Figure 2 – A, B - Splenic parenchyma with multiple fibrotic whitish spots (iron deposits) and well circumscribed 
congested/ hemorrhagic nodules; C - Photomicrography - Splenic parenchyma with decrease in white pulp, 
areas of fibrosis, hemorrhage, calcification and hemosiderin deposition (H & E, 50X); D - Photomicrography - 
Transition between the splenic parenchyma and the well defined congested/ hemorrhagic areas (H & E, 50X).
The examination of esophagus, stomach, 
pancreas, small and large intestine, adrenal glands, 
bladder, prostate, gall bladder, thyroid and testicles 
was unremarkable.
The reserch for deep venous thrombosis 
was confined to territory of the iliac and femoral 
veins, wich failed to demonstrate thrombi presence.
DISCUSSION
We report a case of hemoglobin SC 
disease disease complicated by fatal pulmonary 
thromboembolism in a 15 year-old Brazilian boy, 
submitted to autopsy.
It has been estimated that approximately 
7% of the world population are carriers of inherited 
haemoglobin disorders. The structural haemoglobin 
variants result from single amino-acid substitutions 
in the alfa or beta chains.1,2
Sickle cell disease (SCD) is a generic term 
that comprises a group of hereditary hemolytic 
anemia characterized by the production of 
hemoglobin S (HbS). The diagnosis is based on 
the analysis of hemoglobin by electrophoresis or 
chromatography.3-5
HbS is caused by a mutation in the β-globin 
gene in which the sixth aminoacid in the β-globin 
chain becomes valine instead of glutamic acid. 
HbC is also caused by a mutation in the beta chain, 
resulting in the substitution of glutamic acid by 
lysine.2-4,6,7
Hemoglobin HbS shows peculiar biochemical 
properties, which leads to polymerization when 
deoxygenated. HbS polymerization leads to 
sickling of red blood cells. This process alters the 
cell membrane properties, which reduce cellular 
flexibility and lead to enhanced cell adherence to 
vascular endothelium.4,7
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Figure 3 – Photomicrographs: A - Histological aspect of the well circumscribed congested/ hemorrhagic 
area. (H & E, 100X); B - Gamna-Gandy bodies (H & E, 200X); C - Splenic parenchyma with areas of fibrosis 
(blue) (Masson, 200X); D - Splenic parenchyma with hemosiderin deposition (blue) (Perls, 100X).
Figure 4 – A - Macroscopic aspect of liver; B - Hepatic congestion with the presence of sickle red blood cells 
and a slight lymphocytic infiltrate in portal tract (H & E, 200X).
The presence of hemoglobin HbC in 
erytrocytes increases the intracellular hemoglobin 
concentration by loss of water and K+. This process 
increases the tendency of HbS to polymerize.8
The most common form of SCD is sickled 
cell anemia, caracterized by homozygosity for the 
βS allele (HbSS). Hemoglobin SC disease (HbSC) 
is characterized by equal concentrations of HbS 
and HbC, as in the present case. Individuals with 
HbSC are at risk for the same life-threatening 
complications as HbSS but at a decreased 
tendency. A small subset of HbSC patients has a 
clinical phenotype similar to HbSS (as it seems to 
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Figure 6 – Photomicrography - Hypercellular bone 
marrow with increased erythroid precursors and 
granulocytic lineage cells. Presence of congested 
vessels containing sickle erythrocytes. (H & E, 400X).
Figure 5 – Photomicrographs: A - Glomerular congestion (H & E, 400X); B - Congested renal vessels with 
sickle erytrocytes in the renal medulla. (H & E, 400X).
be the case of this pacient). It is associated with 
important complications, including aseptic necrosis 
of the femoral or humeral heads, haematuria, 
proliferative retinopathy, and a thrombotic 
tendency.2,8
The pathophysiologic hallmark of SCD is 
episodic occurrence of vasoocclusive events that 
precipitate acute painful episodes. These recurrent 
episodes of ischaemia and inflammation result in 
progressive damage to the brain, kidneys, lungs, 
bones, cardiovascular system resulting in organic 
failures and death. These ischemic episodes 
are often followed by restoration of blood flow, 
which promotes tissue injury, caused by oxidant 
stress.6,9-11
The occlusive events within the 
microcirculation result from a complex scenario 
involving the interactions between dense dehydrated 
sickle cells, platelets, reticulocytes, abnormally 
activated endothelial cells, leukocytes, plasma 
factors, cytokines and oxidized pro-inflammatory 
lipids.12,13
Other important pathologic mechanism 
involves the release of haemoglobin into the 
circulation during intravascular hemolysis. The 
released hemoglobin produces reactive oxygen 
species, which is a potent scavenger of nitric 
oxide, causing vasoconstriction. Furthermore, the 
hemoglobin release inhibits endothelial nitric oxide 
signalling, leading to endothelial cell dysfunction 
and nitric oxide resistance.6,7
In patients with sickle cell disease there is a 
hypercoagulable state due to high levels of thrombin, 
abnormal activation of fibrinolysis, decreased levels 
of anticoagulant proteins, activation of platelets 
and increased circulating levels of soluble tissue 
factor.3,14,15
The painful vasoocclusive crises and 
osteomyelitis represent the most frequent 
complications requiring hospital admissions among 
patients with SCD. Other common complications 
are: funcional asplenia, splenic sequestration, acute 
chest syndrome (ACS), osteonecrosis (avascular 
necrosis), septic arthritis, dactylitis, cerebral infarcts, 
pulmonary hypertension, pulmonary embolism, renal 
infarction with papillary necrosis, renal medullary 
fibrosis with focal segmental glomerulosclerosis, 
retinopathy, thrombotic strokes, leg ulcers, fatigue, 
and cholelithiasis.6,12,16,17
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In this case, the patient although young, 
already had severe complications related to SCD, 
such as osteonecrosis, functional asplenia and 
suspected septic arthritis. In patients with SCD, the 
spleen is almost always affected by microinfarcts, 
resulting in hyposplenism or asplenism.18
The aspect of spleen results from recurrent 
episodes of ischemic/inflammatory insults and intra-
splenic hemolysis, culminating with fibroinflamatory 
reaction, deposition of calcium and hemossiderin. 
The well circumscribed round areas correspond to 
nodules of regeneration and consist of preserved 
and congested spleen parenchyma. The explanation 
for these pseudotumoral areas is still unknown.19-21
The most common cause of death for all sickle 
variants and for all age groups is infection/sepsis 
and death is frequently sudden and unexpected, as 
in the case reported.22
A large portion of the sudden death occurs 
beacause of pulmonary complications, like ACS, 
thromboembolism, pulmonary hypertension, lung 
edema and fat/bone marrow embolism. In our case, 
there was no clinical/radiologic information required 
for the diagnosis of ACS, wich is defined by a recent 
pulmonary infiltrate involving at least one complete 
lung segment, associated to a temperature of more 
than 38.5 °C or respiratory symptoms, like chest 
pain, tachypnea, wheezing or cough.19,23-25
The patient presented acute episode of 
tachydyspnea and sudden death on the postoperative 
period. The post-mortem examination confirmed the 
diagnosis of pulmonary thromboembolism.
Pulmonary thromboembolism is not the most 
common acute pulmonary complication among 
SCD patients, but it has to be remembered that 
HbSC disease’s hypercoagulable state besides the 
orthopedic post-operatory facilitates the occurrence 
of thromboembolic events, even in young patients.
CONCLUSION
This autopsy case draws the attention to the 
the importance of early diagnosis and permanent 
treatment and control of sickle cell disease, 
which may lead to systemic involvement in youth, 
moreover to the importance of the hypercoagulability 
observed in these patients, particulary in situations 
of increased risk of thromboembolism such 
as the post-operatory. Description of the florid 
morphological aspects of this disease at autopsy is 
instructive and not well explored in the literature.
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